期刊文献+

去甲氧柔红霉素联合阿糖胞苷、柔红霉素治疗急性髓系白血病的效果

下载PDF
导出
摘要 目的:探讨采用去甲氧柔红霉素(IDA)联合阿糖胞苷对急性髓系白血病(AML)患者进行治疗的效果。方法:选取韶关市粤北人民医院2017年8月至2020年8月期间收治的60例AML患者,按照随机数字表法分为对照组与观察组,各30例。对照组采用柔红霉素联合阿糖胞苷治疗,观察组在对照组基础上联用IDA治疗,比较两组患者的临床疗效与毒副作用。结果:两组患者的治疗总有效率比较,差异无统计学意义(P>0.05);观察组患者不良反应发生率为36.7 %(11/30)低于对照组的66.7 %(20/30),差异具有统计学意义(P<0.05)。结论:IDA与阿糖胞苷联合治疗急性髓系白血病,可获得较好的临床总体疗效,同时可帮助患者在治疗期间减少不良反应。
作者 廖建军
出处 《深圳中西医结合杂志》 2020年第23期154-155,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献7

二级参考文献89

  • 1冀晓红.糖胺聚糖方案治疗老年急性髓系白血病的疗效及预后影响因素[J].中国老年学杂志,2015,35(2):374-375. 被引量:6
  • 2卞寿庚,郝玉书.成人急性非淋巴细胞白血病化疗的研究[J].中华血液学杂志,1993,14(2):59-62. 被引量:16
  • 3MandelliF, VignettiM, SuciuS, et al. Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10[J]. J Clin Oncol,2009,27(32):5397-5403. doi:10.1200/JCO.2008.20.6490.
  • 4LeeJH, JooYD, KimH, et al. A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia[J]. Blood,2011,118(14):3832-3841. doi:10.1182/blood-2011-06-361410.
  • 5SwerdlowSH, CampoE, HarrisNL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M].4th, ed. Lyon, France:IARC Press,2008:109-139.
  • 6SlovakML, KopeckyKJ, CassilethPA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study[J]. Blood,2000,96(13):4075-4083.
  • 7DohnerH, EsteyEH, AmadoriS, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet[J]. Blood,2010,115(3):453-474. doi:10.1182/blood-2009-07-235358.
  • 8ChesonBD, BennettJM, KopeckyKJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia[J]. J Clin Oncol,2003,21(24):4642-4649.
  • 9MillerAB, HoogstratenB, StaquetM, et al. Reporting results of cancer treatment[J]. Cancer,1981,47(1):207-214.
  • 10WeickJK, KopeckyKJ, AppelbaumFR, et al. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study[J]. Blood,1996,88(8):2841-2851.

共引文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部